• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Friday, June 5, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Gilgit Baltistan Election
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

Proposed retina specialists denied access to Imran Khan

Published on: February 20, 2026 10:15 AM

Three retina specialists recommended for examining incarcerated Pakistan Tehreek-e-Insaf (PTI) founder Imran Khan were not granted permission to see him regarding his eye condition.

Read More: Naqvi rejects claims over Imran Khan eye treatment

According to sources, Aasim Yusuf, Chief Medical Officer at Shaukat Khanum Memorial Cancer Hospital & Research Centre, had proposed three retina experts and shared their names with PTI leader Salman Akram Raja. However, none of the suggested doctors were allowed to examine the former prime minister.

The recommended specialists were Aamir Awan, Mazhar Ishaq and Waqar Mazhar from Al-Shifa International Hospital, sources said.

Instead, Nadeem Qureshi conducted the examination, accompanied by Arif Khan from Pakistan Institute of Medical Sciences (PIMS). Sources added that after Dr. Aasim Yusuf and Khurram Mirza were not permitted to visit Adiala Jail, another doctor from Al-Shifa was dispatched instead.

Imran Khan received his first eye injection on January 25, while a second injection is scheduled for February 25. It remains undecided whether the next procedure will take place inside the jail or at a hospital.

Earlier, a medical report dated February 15, 2026, detailed findings of a board examination conducted at Adiala Jail. The board later briefed PTI leaders Barrister Gohar Ali Khan and Raja Nasir Abbas at PIMS and also consulted Khan’s personal physicians by phone. Both political and medical representatives expressed satisfaction with the treatment plan.

Read More: Imran Khan shifted to Pims for eye treatment

The report noted improvement in the right eye’s vision from 6/36 to 6/9 (partial) following treatment, with reduced swelling described as encouraging. Doctors recommended continuing prescribed eye drops and ongoing therapy, with a second anti-VEGF injection and advanced imaging tests, including OCT angiography, to be considered if needed.

Filed Under: Pakistan Tagged With: Adiala Jail, Al-Shifa Hospital, eye treatment, Imran Khan, Latest, lead3, PIMS, PTI

Submit a Comment




Primary Sidebar




Latest News

Pakistan secured a convincing 3-0 victory over the Maldives

Oil falls on hopes of broader peace after Lebanon, Israel halt fighting

Meat exports grow by 4.16%

SBP-held foreign reserves rise by $43m to $17.9bn

Gold prices up by Rs 1,523 per tola

Pakistan

Bilawal seeks heavy public mandate to protect GB’s rights

PM directs pilot launch of automated tax collection system in Islamabad

Federal budget on June 10

PM hails special ties with Washington at event marking US 250th anniversary

FO rubbishes reports of Dar sharing Iran nuclear information with Rubio

More Posts from this Category

Business

Rupee strengthens against dollar

Pakistan’s exports to US up by 1.70% to $5.12bn in 10 months

Pakistan, Tajikistan set $200 million trade target, deepen ties at 8th JCM

Services’ exports up by 17.68% to $8.26bn

OGDCL’s new wells deliver record oil, gas output in FY26

More Posts from this Category

World

No sign of progress in US-Iran talks as Hezbollah rejects truce

Vast accelerates race to replace ISS

Gulf crisis drives India-Venezuela oil partnership

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.